神经血栓切除设备市场－全球产业规模、份额、趋势、机会与预测、按产品、按最终用户、按地区和竞争情况细分，2020-2030 年

2024 年全球神经血栓切除设备市场价值为 7.394 亿美元，预计到 2030 年将达到 11.0597 亿美元，预测期内的复合年增长率为 6.90%。这一增长主要得益于全球缺血性卒中患病率的上升以及对先进机械血栓切除干预措施的需求不断增长。神经血栓切除设备（例如支架取栓器、抽吸导管和血管圈套器）对于清除大血管闭塞 (LVO) 患者的血栓至关重要，可显着改善急性缺血性中风病例的预后。技术创新和诊断影像的改进使得能够更早、更准确地识别符合条件的患者，从而支持更广泛地采用这些挽救生命的干预措施。儘管挑战依然存在，尤其是在资源匮乏的地区，专科医生的可用性和手术的可及性方面，但预计对卒中治疗基础设施的投资不断增加以及设备功能的持续进步将维持全球市场扩张。

关键市场驱动因素

全球缺血性中风和大血管闭塞发生率上升

主要市场挑战

熟练的神经介入专家短缺

主要市场趋势

新兴市场中风护理基础设施的扩展

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：神经血栓切除设备市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 副产品（血块取出器、抽吸装置、血管圈套器）
  • 按最终用户（医院、急诊、门诊手术中心）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美神经血栓切除设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲神经血栓切除设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太神经血栓切除设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲神经血栓切除术设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲神经血栓切除术设备市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 13 章：全球神经血栓切除术设备市场：SWOT 分析

第 14 章：竞争格局

• Medtronic Plc.
• Stryker Corporation
• Acandis GmbH
• Phenox GmbH
• Penumbra Inc.
• Vesalio

第 15 章：策略建议

第16章调查会社について・免责事项

The Global Neurothrombectomy Devices Market was valued at USD 739.40 Million in 2024 and is projected to reach USD 1105.97 Million by 2030, growing at a CAGR of 6.90% during the forecast period. This growth is primarily fueled by the rising global prevalence of ischemic strokes and the increasing need for advanced mechanical thrombectomy interventions. Neurothrombectomy devices-such as stent retrievers, aspiration catheters, and vascular snares-are central to removing clots in patients with large vessel occlusions (LVOs), significantly improving outcomes in acute ischemic stroke cases. Technological innovation and improved diagnostic imaging are enabling earlier and more accurate identification of eligible patients, supporting broader adoption of these life-saving interventions. Although challenges remain, particularly around specialist availability and procedural access in low-resource settings, growing investment in stroke treatment infrastructure and ongoing advancements in device capabilities are expected to sustain market expansion globally.

Key Market Drivers

Rising Global Incidence of Ischemic Stroke and Large Vessel Occlusions

Ischemic stroke continues to be a leading cause of death and long-term disability worldwide, accounting for approximately 85% of all stroke events. A large subset of these are large vessel occlusions (LVOs), which require urgent intervention to restore cerebral perfusion. More than 12 million strokes occur globally each year, with a substantial portion reported in low- and middle-income regions. This increase is linked to risk factors such as aging populations, sedentary habits, and rising incidences of hypertension, diabetes, and obesity.

LVOs, in particular, necessitate mechanical thrombectomy procedures as they are often unresponsive to intravenous thrombolytic therapy. The use of advanced imaging techniques like CT angiography has enhanced the ability of clinicians to detect LVOs early, increasing the number of patients eligible for intervention. As a result, the clinical demand for neurothrombectomy devices continues to grow, particularly in stroke-ready hospitals and neurointervention centers worldwide.

Key Market Challenges

Shortage of Skilled Neurointerventional Specialists

The expansion of the neurothrombectomy devices market is constrained by a shortage of trained neurointerventional professionals. Mechanical thrombectomy is a technically demanding procedure that requires real-time imaging, expert handling of advanced devices, and multidisciplinary support. Many countries-especially in parts of Asia, Africa, and Latin America-lack adequate training programs and medical infrastructure to perform these procedures at scale.

Even in well-developed healthcare systems, the demand for thrombectomy can exceed available resources, resulting in treatment delays. The scarcity of qualified specialists not only limits procedural accessibility but also reduces patient throughput and clinical outcomes, posing a significant barrier to full market potential.

Key Market Trends

Expansion of Stroke Care Infrastructure in Emerging Markets

To address the growing burden of stroke, many emerging economies are prioritizing investment in dedicated stroke care facilities and interventional capabilities. Healthcare systems across Asia-Pacific, Latin America, and the Middle East are establishing new stroke centers, rolling out mobile stroke units, and training local specialists in neurointerventional techniques.

International organizations and private healthcare providers are also investing in tele-stroke services, enabling remote diagnosis and timely transfer of patients to thrombectomy-equipped hospitals. These efforts are improving procedural access in previously underserved areas and are expected to increase demand for devices such as stent retrievers and aspiration systems. As stroke care systems become more robust and widespread, market opportunities are expanding well beyond traditional strongholds in North America and Europe.

Key Market Players

• Medtronic Plc.
• Stryker Corporation
• Acandis GmbH
• Phenox GmbH
• Penumbra Inc.
• Vesalio

Report Scope:

In this report, the Global Neurothrombectomy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Neurothrombectomy Devices Market, By Product:

• Clot Retrievers
• Aspiration/ Suction Devices
• Vascular Snares

Neurothrombectomy Devices Market, By End User:

• Hospital
• Emergency Clinics
• Ambulatory Surgical Centers

Neurothrombectomy Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Neurothrombectomy Devices Market.

Available Customizations:

Global Neurothrombectomy Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Neurothrombectomy Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Clot Retrievers, Aspiration/ Suction Devices, Vascular Snares)
  • 5.2.2. By End User (Hospital, Emergency Clinics, Ambulatory Surgical Centers)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Neurothrombectomy Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Neurothrombectomy Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Neurothrombectomy Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Neurothrombectomy Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End User

7. Europe Neurothrombectomy Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Neurothrombectomy Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End User
  • 7.3.2. United Kingdom Neurothrombectomy Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End User
  • 7.3.3. Italy Neurothrombectomy Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End User
  • 7.3.4. France Neurothrombectomy Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Neurothrombectomy Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By End User

8. Asia-Pacific Neurothrombectomy Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Neurothrombectomy Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End User
  • 8.3.2. India Neurothrombectomy Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Neurothrombectomy Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Neurothrombectomy Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Neurothrombectomy Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By End User

9. South America Neurothrombectomy Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Neurothrombectomy Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Neurothrombectomy Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Neurothrombectomy Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End User

10. Middle East and Africa Neurothrombectomy Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Neurothrombectomy Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Neurothrombectomy Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Neurothrombectomy Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Neurothrombectomy Devices Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Medtronic Plc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Stryker Corporation
• 14.3. Acandis GmbH
• 14.4. Phenox GmbH
• 14.5. Penumbra Inc.
• 14.6. Vesalio

15. Strategic Recommendations

16. About Us & Disclaimer